This may be the most exciting up and coming biomedical company of 2021!

     [This small-cap biomedical company is bursting the bubble of what is considered “the norm” in addiction therapy and is paving its way as one of the most exciting biotechnology companies to be watching!](  According to the [CDC]( – there were an estimated 100,306 overdose deaths in the United States between May 2020 and April, 2021. This is startling and shows that the current method of recovery is simply not enough! One under the radar Canadian based small-cap company is using psychoactive drugs to treat substance abuse disorders that could be a game changer!  The potential of investing in the psychedelic market is unstoppable in growth. The company is using non-traditional forms of recovery, focusing primarily on the powerful DMT molecule. DMT is unique among hallucinogens in that it is endogenous in the human body and has been clinically validated as being safe for human consumption. The company has an upcoming human trial, planned to be the most rigorous and comprehensive study of DMT to date!  DMT is more unexplored in the world of biomedicine, which makes this company an exciting revolutionary to pay attention to…  [Read on to see why this small-cap company could be an exciting game changer in the biomedical industry!](   ---------------------------------------------------------------      This email was sent to {EMAIL} by editor@marketmovingtrends.com MarketMovingTrends, 45 South Park Place, #203, Morristown, NJ 07960 United States  [Unsubscribe]( | [Report Spam]( Â